Prof. Sheng Cai received the B.Sc. degree in Pharmacy from College of Pharmaceutical Sciences, Zhejiang University, in 2007, and the Ph.D. degree in Pharmaceutical Analysis from School of Pharmacy, Fudan University, in 2013. From 2015 to 2016, he was a visiting scholar at the Center for Systems and Synthetic Biology, University of Texas at Austin. Since 2013, he has been an assistant professor and associate professor in the College of Pharmaceutical Sciences at Zhejiang University. His research interests mainly focus on the following: (1) new chemiluminescence and fluorescence biosensor technologies; the development of analytical tools for enhanced biomedical studies using nanotechnology and nanomaterials, designing novel molecular probes that can be used in the areas of chemical and biological sensing, application of molecular aptamers in biosensors, and the (2) in vivo pharmacokinetics research of protein drugs in animals. He is currently a member of the Drug Analysis Technology Special Committee of the Chinese Association of Biomedical Technology and deputy director of the Youth Committee, a member of the Epigenetic Pharmacology Special Committee of the Chinese Pharmacological Society, a member of the Analytical Pharmacology Special Committee of the Chinese Pharmacological Society, and a member of the Zhejiang Pharmaceutical Society. He is the deputy director of the Youth Committee of the Pharmaceutical Analysis Professional Committee.
Prof. Sheng Cai received the B.Sc. degree in Pharmacy from College of Pharmaceutical Sciences, Zhejiang University, in 2007, and the Ph.D. degree in Pharmaceutical Analysis from School of Pharmacy, Fudan University, in 2013. From 2015 to 2016, he was a visiting scholar at the Center for Systems and Synthetic Biology, University of Texas at Austin. Since 2013, he has been an assistant professor and associate professor in the College of Pharmaceutical Sciences at Zhejiang University. His research interests mainly focus on the following: (1) new chemiluminescence and fluorescence biosensor technologies; the development of analytical tools for enhanced biomedical studies using nanotechnology and nanomaterials, designing novel molecular probes that can be used in the areas of chemical and biological sensing, application of molecular aptamers in biosensors, and the (2) in vivo pharmacokinetics research of protein drugs in animals. He is currently a member of the Drug Analysis Technology Special Committee of the Chinese Association of Biomedical Technology and deputy director of the Youth Committee, a member of the Epigenetic Pharmacology Special Committee of the Chinese Pharmacological Society, a member of the Analytical Pharmacology Special Committee of the Chinese Pharmacological Society, and a member of the Zhejiang Pharmaceutical Society. He is the deputy director of the Youth Committee of the Pharmaceutical Analysis Professional Committee.